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Insect blood cells (hemocytes) comprise an essential arm of
the immune system [1–7]. Several factors mediating recogni-
tion and phagocytosis of foreign intruders by hemocytes
have been identified, but the mechanisms regulating hemo-
cyte movement remain fragmentary. Embryonic hemocytes
from Drosophila migrate along stereotypical routes in
response to chemotactic signals from PVF ligands,
members of the platelet-derived growth factor family
[8–12]. Embryonic and larval hemocytes also accumulate
at external wounds [11–13], but PVFs are not required for
this response, suggesting involvement by other, unknown
factors. Here we report the identification of hemocyte
chemotactic peptide (HCP) from the moth Pseudaletia sepa-
rata and present evidence that it stimulates aggregation and
directed movement of phagocytic hemocytes. Spatiotem-
poral studies revealed that HCP is expressed in both
epidermal cells and hemocytes, whereas structure-function
studies identified post-translational modifications important
for activity. HCP also shares similarities with another group
of cytokines from moths called ENF peptides [14–17]. Taken
together, our results identify HCP as a chemotactic cytokine
that enhances clotting at wound sites in larvae.
Results and Discussion
P. separata is a common pest of rice in Asia. Circulating hemo-
cytes in P. separata larvae, like other Lepidoptera, consist of
four subpopulations: granulocytes, plasmatocytes, spherule
cells, and oenocytoids, which are distinguished from one
another by morphological, molecular, and functional charac-
ters [2–4, 18]. Granulocytes are the most abundant hemocyte
type that upon activation rapidly adhere to foreign surfaces,
are phagocytic, and secrete effector molecules including
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cells that in cooperation with granulocytes form capsules
around large intruders like parasitoid wasps. Granulocytes
and plasmatocytes also aggregate at external wound sites in
association with clotting. Oenocytoids are nonadhesive hemo-
cytes that produce components of the phenoloxidase cascade
whereas spherule cells are nonadhesive cells that are a poten-
tial source of cuticular proteins.
As observed in other insects [13, 18–20], hemocytes from
last-stage (sixth instar) P. separata larvae rapidly aggregate
at external wound sites (Figure S1 available online). As a first
step in investigating the factors regulating this response, we
prepared an integument extract and conducted two types of
in vitro bioassays. An aggregation assay revealed integument
extract dose dependently induced hemocyte aggregation, and
a migration assay conducted in transwell chemotaxis cham-
bers indicated that integument extract dose dependently stim-
ulated the preferential migration of granulocytes (Figure S1).
We also determined that boiling yielded a supernatant with bio-
logical activity identical to the crude extract, whereas treatment
of the supernatant with trypsin eliminated activity (data not pre-
sented). Taken together, these results suggested that aggrega-
tion of hemocytes at external wounds in P. separata larvae
involved release of a peptidyl factor(s) from the integument.
Identification of HCP
To identify this factor, four analytical high-performance liquid
chromatography (HPLC) runs coupled with bioassays yielded
isolation of a fraction we named HCP (Figure S2). N-terminal
sequencing of purified HCP identified a 21 amino acid
sequence but MALDI-TOF MS analysis indicated the molec-
ular mass was 3982 Da (M + H+), suggesting that this sequence
was truncated. We therefore prepared cDNAs from total RNA
isolated from P. separata larval integument and used RACE
PCR methods to clone a 348 bp hcp cDNA (Figure 1A). The
deduced protein encoded by hcp was 52 amino acids with an
N-terminal signal sequence that SignalP3.0 (http://www.cbs.
dtu.dk/services/SignalP/) predicted is cleaved after Ser20
followed by a 32 amino acid C-terminal domain (Figure 1A).
The first 21 residues of the C-terminal domain matched identi-
cally the sequence obtained for HCP purified by HPLC
(Figure 1A), whereas hybridization of hcp to a single mRNA
of similar size on northern blots indicated that the clone was
full-length (Figure S3). Overall, these results indicated that hcp
encodes a small, secreted protein of 32 amino acids, but the
predicted molecular mass for this peptide (3543 Da) remained
439 Da less than that determined for purified HCP.
Trypsinization of synthetic and purified HCP followed by
comparison of the resulting fragments by LC-ESI-MS/MS
resolved this discrepancy by revealing Met11 and Met13
from purified HCP were oxidized whereas Thr22 and Thr23
were O-glycosylated with N-acetylhexosamines (Figure S4).
These modifications increased the predicted molecular mass
of HCP to 3981 Da, which was identical to the mass deter-
mined for the purified peptide. Characterization of the solution
structure of recombinant HCP by NMR further indicated that
the peptide consists of a well-structured central domain stabi-
lized by a disulfide bond between Cys7 and Cys19 and two
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780flanking domains at the N and C termini that are disordered
(Figure 1B). Database searches failed to identify significant
similarities in primary structure between HCP and known
proteins. However, a partially matching nucleotide sequence
was identified in the genome of the moth Bombyx mori (BM
scaf45 contig24645) with KAIKOBLAST suggesting that other
Lepidoptera encode HCP homologs. We also noted that the
tertiary structure and position of selected residues in HCP
share features with previously identified ENF peptides from
Lepidoptera, which function as plasmatocyte activators
(Figure S6, see Supplemental Results and Discussion).
HCP Is Expressed in Epidermal Cells and Hemocytes
RT-PCR analysis indicated that hcp is constitutively ex-
pressed in P. separata larvae and pupae but is spatially
restricted to the integument, hemocytes, and nervous system
(Figure S3). In situ hybridization localized hcp expression to
the epidermis (Figure 1C), whereas immunocytochemistry
with anti-HCP localized the peptide to the endocuticle
(Figure 1D). In hemocytes, we detected HCP in the cytoplasm
of primarily plasmatocytes (Figures 1E and 1F) although some
plasmatocytes were unlabeled. We also detected HCP in
a small proportion of granulocytes but never detected HCP
in spherule cells or oenocytoids. Wounding did not alter hcp
transcript or protein abundance in the integument as assessed
by real-time PCR analysis and immunoblotting.
Purified HCP Exhibits Enhanced Aggregation
and Chemotactic Activity
To evaluate whether the post-translational modifications iden-






Figure 1. A 348 bp cDNA Encodes HCP, which Is Expressed in Integu-
ment and Hemocytes
(A) Nucleotide sequence of hcp with the deduced amino acid sequence
for the predicted protein shown below the corresponding codons. The
underlined sequence indicates the predicted sequence of HCP whereas
the bold line indicates the amino acid sequence obtained from
N-terminal sequencing of HCP purified from the integument.
(B) Ensemble of 20 HCP conformers after alignment of the backbone
atoms of residues 7–22.
(C) In situ section of integument from sixth instar P. separata probed
with digoxigenin-labeled antisense hcp. The hybridization signal
(purple) localizes to the epidermis with little or no signal detected in
the endocuticle (End.C) or exocuticle (Ex.C). Inset shows integument
hybridized with sense hcp. Note the absence of signal in the epidermis.
(D) Immunocytochemical section of integument probed with anti-HCP
and visualized with an HRP-conjugated secondary antibody. HCP is
detected in the endocuticle (brown) (scale bar represents 300 mm). Inset
shows integument probed with HCP preimmune serum.
(E and F) Immunocytochemical visualization of HCP in hemocytes from
sixth instar larvae with anti-HCP visualized via an Alexa 488-conjugated
secondary antibody. A phase-contrast micrograph (E) and the corre-
sponding fluorescent image (F) are shown (scale bar represents
100 mm). HCP is detected predominantly in plasmatocytes (Pl).
compared the aggregation response of hemocytes to puri-
fied and synthetic HCP. Purified HCP induced a significantly
greater aggregation response than did synthetic HCP at all
concentrations tested (Figure 2A). Transwell assays indi-
cated that purified HCP also induced a stronger migration
response than synthetic HCP over a concentration range
of 20 and 200 nM (Figure 2B). The majority of hemocytes
(81%) that moved to the lower chamber were also granulo-
cytes as found for crude integument extract (see Figure S1).
We recognized that hemocyte migration to the lower
chamber could reflect either a chemokinetic or chemotactic
response to HCP. To distinguish between these possibilities,
we added 0.2 mM of purified HCP to both the upper and lower
chamber, which would be predicted to reduce hemocyte
movement to the lower chamber if HCP is chemotactic but
not reduce movement if chemokinetic. Our results indicated
that HCP in both chambers reduced hemocyte movement to
near control levels (Figure 2B). Additional evidence for the
chemotactic activity of HCP derived from assays with the
EZ-TAXIScan platform, which measures single-cell movement
to a concentration gradient. These experiments indicated that
purified HCP stimulated directional movement of hemocytes
and that the number of responding cells increased with HCP
concentrations (Figure 2C). We also conducted antibody
neutralization experiments with our transwell assay to assess
whether other factors in integument besides HCP stimulated
hemocyte migration. Addition of integument extract plus pre-
immune serum to the lower chamber resulted in a hemocyte
migration response similar to purified HCP alone, whereas
the combination of integument extract plus anti-HCP or puri-
fied HCP + anti-HCP reduced hemocyte migration to similar
levels as observed when no HCP was present (Figure 2D).
These results indicated that anti-HCP had strong neutralizing
activity and also suggested that HCP is the primary factor in
integument mediating hemocyte movement.
Immunodepletion of HCP Increases Blood Loss
after External Wounding
Adult insects possess a rigid integument and their hemocoels
usually contain low volumes of hemolymph where hemocytes




Figure 2. Purified HCP Exhibits Greater Biological Activity than Does Synthetic HCP
(A) Dose-dependent effects of synthetic and purified HCP on hemocyte aggregation in vitro (n = 6 per treatment). Aggregation indexes were determined as
described in Figure S1. Asterisks above bars for a given peptide concentration indicate that purified HCP induced a significantly stronger response than did
synthetic HCP (t test; p < 0.05).
(B) Dose-dependent effects of synthetic and purified HCP in the lower chamber of transwell chemotaxis chambers on hemocyte migration (n = 6 per treat-
ment). Migration indexes were determined as described in Figure S1. Asterisks indicate that purified HCP induced a significantly stronger migration
response than did synthetic HCP (t test; p < 0.05). Addition of purified HCP (0.2 mM) to both the upper and lower chambers is indicated by the bar labeled
0.2 U–0.2L.
(C) Dose-dependent migration of hemocytes in medium containing 0.1–10 nM purified HCP or 10 nM BSA (negative control) with the EX-TAXIScan assay.
The EZ-TAXIScan apparatus counted the total number of hemocytes that migrated R50 mm in one half of the microchannel. The micrographs below the
graph show hemocyte chemotaxis toward 10 nM purified HCP in the 260 mm microchannel of the apparatus. The left image shows hemocytes (1 3 103)
at the beginning of the assay (0 min) aligned on the bottom edge of the microchannel. Medium containing 0.1 nM HCP was injected into the opposite
compartment (top) resulting in formation of a concentration gradient. The single cell in the middle of the channel at 0 min is due to the drawing of medium
when aligning the cells. The right image shows the same microchannel at 60 min with numerous hemocytes (primarily granulocytes) migrating toward HCP.
(D) Hemocyte migration in transwell chemotaxis chambers to integument extract (0.1 mg/ml) plus preimmune serum (1:100 dilution) (Integ), integument
extract (0.1 mg/ml) plus anti-HCP antibody (1:100 dilution) (Integ+Ab), or HCP (0.2 mM) plus anti-HCP antibody (1:100) (HCP + Ab) (n = 6 per treatment).
Anti-HCP significantly reduced migration relative to preimmune serum (F-test; p < 0.001).contrast, most larval stage insects including Lepidoptera have
a flexible integument and hemocoels that contain large
volumes of hemolymph in which most hemocytes circulate
[13, 22]. A soft, pliable cuticle is likely an adaptation foraccommodating the rapid growth that occurs during the larval
stage but it also renders larvae more vulnerable to significant
blood loss if wounded. We thus hypothesized that HCP func-
tions as a component of the basal immune response with








Figure 3. HCP Reduces Blood Loss and Stimulates Release of HCP from Hemocytes
(A) HCP from integument rapidly forms a concentration gradient. Fragments of integument (ca. 1 3 1 mm) were placed in one end of a primary culture
chamber (9 cm long3 3 mm wide) in 3 ml of ExCell 420 medium. HCP concentration was then measured by ELISA at 1.5 cm intervals by removing an aliquot
of medium after 20 min (n = 3 replicates).
(B–E) Immunodepletion of HCP increases blood loss and decreases accumulation of hemocytes at wound sites.
(B) Two hours after injection of anti-HCP or preimmune serum (10 mg/larva), a single proleg was severed (n = 12 larvae for each treatment) and the amount of
blood loss was determined after 20 min. Larvae injected with anti-HCP lost significantly more hemolymph than did larvae injected with preimmune serum
(t test; p% 0.01).
(C) Photographs of larvae before injection and wounding and at the end of the assay. Larvae are clearly larger before antibody injection and wounding
(before injection) than after. At the end of the assay, larvae treated with anti-HCP are also smaller than larvae treated with preimmune serum (Control
Ab) resulting from greater loss of hemolymph.
(D and E) Phase-contrast micrographs of wounded integument from larvae treated with preimmune serum (D) versus anti-HCP (E). Large numbers of aggre-
gated hemocytes (Hn) are bound to the damaged integument (Integ) in the preimmune serum treatment, whereas few hemocytes are attached to the integ-
ument in the anti-HCP treatment. Scale bar in (D) represents 200 mM.
(F) Purified HCP and bacteria stimulate release of HCP from hemocytes. Ten fmol of purified HCP or 13 104 heat-killed E. cloacae cells were added to hemo-
cytes in 100 ml of ExCell medium. Addition of 10 fmol BSA to cells served as the control. The amount of HCP (fmol) in hemocytes was then determined at 1 min
intervals after treatment by ELISA.
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783wounding of the integument resulting in exposure of the endo-
cuticle to the hemocoel. As a result, HCP is released into
hemolymph, which activates and recruits circulating hemo-
cytes to the site of injury. Because our data indicate that
HCP is expressed in hemocytes, we further hypothesized
that hemocytes also release HCP in response to wounding.
To test these hypotheses, we first confirmed by enzyme-
linked immunosorbant assay (ELISA) that damaged integu-
ment rapidly releases HCP, which forms a concentration
gradient (Figure 3A). We then reasoned that depletion of
HCP after wounding would result in increased blood loss
because of compromised recruitment of hemocytes. We
tested this by a neutralization approach founded on our
in vitro data (Figure 2D) and the broader literature in which im-
munodepletion is often used to selectively remove coagulation
factors from vertebrate plasma. These experiments indicated
that larvae preinjected with anti-HCP lost significantly more
hemolymph than did control larvae injected with preimmune
serum (Figures 3B and 3C). This effect also correlated with
differential accumulation of hemocytes at the wound site
(Figures 3D and 3E). We then examined whether hemocytes
release HCP in response to two factors that are introduced
into the hemocoel upon wounding: bacteria from the surface
of the larva and HCP itself. Our results indicated that both
caused hemocytes in primary culture to rapidly release HCP
as evidenced by decreased HCP levels in hemocytes them-
selves (Figures 3F–3J) and a concomitant rise in HCP concen-
tration in the medium (data not shown).
Unlike embryos and presumably adults [8–12, 21], live
imaging studies in Drosophila larvae indicate that hemocytes
arrive at sites of injury by direct capture from circulation of indi-
vidual cells or clusters (= aggregations) [13]. Our results indi-
cate that localization to the endocuticle isolates HCP from
hemocytes under homeostatic conditions but that wounding
stimulates rapid release of HCP into circulation. This response
initially induces aggregation of circulating hemocytes in prox-
imity to the wound, but is also reinforced through HCP and/or
bacteria-induced release of HCP from hemocytes themselves.
Upon binding to the damaged integument, we speculate that
HCP mediates chemotactic movement of individual hemo-
cytes to fill the wound. This model is diagrammed in Figure 4.
Conclusions
Chemokines are functionally defined as small, secreted cyto-
kines that mediate immune cell activation and migration,
whereas vertebrate chemokines are structurally classified on
the basis of cysteine residue spacing patterns [23, 24]. No
homologs of vertebrate chemokine family members have
been identified in invertebrates including insects. However,
other factors likely function as invertebrate chemokines given
that hemocytes exhibit migratory behavior [9, 11–13]. Our
results support the conclusion that HCP functions as an inver-
tebrate chemokine. That the primary responding hemocytes
are granulocytes is also fully consistent with their role as the
professional phagocytes in Lepidoptera [3] and the need for
rapid clearance of microbes, which otherwise would enter
the insect’s hemocoel after wounding. Release of HCP from
hemocytes after exposure to bacteria or HCP itself further
suggests an amplification mechanism for enhancing clotting.HCP adopts a tertiary structure comprised of a disordered
N terminus of six amino acids, a structured domain distin-
guished by a type II b-turn and disulfide bond for stabilizing
overall topology, and a disordered C terminus in which Thr22
and Thr23 are glycosylated. Despite low sequence homology,
these features strongly resemble ENF peptides that induce
adhesion and chemokinetic movement of plasmatocytes [16,
25–29]. In addition to the importance of the structured core
of ENF peptides for biological activity, their conserved six
amino acid N termini serve as an essential signaling domain,
which is highly sensitive to length and specific functional
groups including a charged N-terminal amine [30–32]. Whether
the N-terminal domain is similarly essential for the biological
activity of HCP is unknown, although we think it likely given
these structural similarities. We thus conclude that HCP and
ENF peptides share sufficient features with one another to
consider them members of a family of insect cytokines.
Although clearly not homologs of vertebrate chemokines,
HCP and other ENF peptides do exhibit structural determi-
nants shared with some vertebrate chemokine family
members. Similar to ENF peptides, for example, the activity
of the CC subfamily chemokines CCL2 (MCP-1) and CCL5
(Rantes) critically depends on the length of their N termini
Figure 4. Model of HCP Activity after External Wounding of P. separata
The top of the figure shows a wounded larva. Below the larva is shown an
enlargement of the wound site with HCP from the endocuticle and bacteria
on the surface of the larva entering the hemolymph at the wound site. HCP
from the endocuticle stimulates aggregation of circulating hemocytes in
proximity to the wound and release of HCP from hemocytes themselves,
which accelerates clotting (see Results and Discussion).(G and H) Light and epifluorescent micrographs of hemocytes before treatment with purified HCP. HCP in hemocytes (green) was visualized with anti-HCP
and an Alexa fluor 488 secondary antibody. Scale bar in (G) represents 120 mm.
(I and J) Light and epifluorescent micrographs of hemocytes 5 min after treatment with purified HCP. Note that almost no HCP is detectable.
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784and the presence of a free N-terminal amine [33–35]. Like HCP,
glycosylation of specific C-terminal domain residues also
significantly enhances biological activity including chemotaxis
of the C subfamily member XCL1 (lymphotactin) [36]. Far less
clear is whether parallels also exist between HCP or other
ENF peptides and vertebrate chemokines in the downstream
signaling factors required for chemotaxis. All known verte-
brate chemokine receptors with signaling activity are also
G protein-coupled receptors (GPCRs) with chemotaxis
requiring activation of phosphatidylinositol 3-kinases (PI3Ks),
the serine/threonine kinase Akt/PK, and one or more Rho
GTPases that modulate polarization of the cytoskeleton [23,
24]. In contrast, little is known of the signaling pathways that
operate in chemotaxing and aggregating hemocytes, although
studies with embryonic hemocytes from Drosophila do
demonstrate a requirement for PI3K in chemotaxis toward
wound sites [12].
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